Literature DB >> 11479062

Ethics and early intervention in psychosis: keeping up the pace and staying in step.

P D McGorry1, A Yung, L Phillips.   

Abstract

The intense clinical and research interest in early psychosis in recent years has highlighted a range of ethical issues which need to be considered carefully. Our perspective is based on 16 years of clinical and research experience with young people at this phase of illness as well as the research contributions of many others. We discuss the ethical dilemmas in relation to the three key foci, which make up the early psychosis paradigm. These are the pre-psychotic or prodromal phase, the period of untreated psychosis and the first psychotic episode and the critical period of recovery, which follows this. Most attention is devoted to the pre-psychotic period, however ethical considerations related to research in the other two clinical foci are briefly covered as well. Our contention is that the ethical issues are essentially identical to those arising in early intervention research in mainstream medicine. This has been concealed by inconsistency and emotion, which has great potential to confuse, politicize and derail rational debate. The legacy of the isolation of psychiatry from medicine and consequent prejudice and stigma in the professional as well as the public mind seems to be fueling a tendency in some societies to view psychiatric research as qualitatively different from other medical research. Sound clinical research data should be allowed to illuminate the options for potential consumers across all phases of illness. The alternative is research paralysis, which would force clinical practice to expand blindly without an evidence base.

Entities:  

Mesh:

Year:  2001        PMID: 11479062     DOI: 10.1016/s0920-9964(01)00235-3

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  34 in total

Review 1.  Early intervention in schizophrenia: three frameworks for guiding ethical inquiry.

Authors:  Philip J Candilis
Journal:  Psychopharmacology (Berl)       Date:  2003-03-25       Impact factor: 4.530

2.  PROD-screen--a screen for prodromal symptoms of psychosis.

Authors:  M Heinimaa; R K R Salokangas; T Ristkari; M Plathin; J Huttunen; T Ilonen; T Suomela; J Korkeila; T H McGlashan
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

3.  Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: an empirical question.

Authors:  Lawrence H Yang; Ahtoy J Wonpat-Borja; Mark G Opler; Cheryl M Corcoran
Journal:  Schizophr Res       Date:  2010-04-18       Impact factor: 4.939

Review 4.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

5.  Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis.

Authors:  Lawrence H Yang; Bruce G Link; Shelly Ben-David; Kelly E Gill; Ragy R Girgis; Gary Brucato; Ahtoy J Wonpat-Borja; Cheryl M Corcoran
Journal:  Schizophr Res       Date:  2015-08-25       Impact factor: 4.939

6.  The future of psychological therapies for psychosis.

Authors:  Philippa A Garety
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

Review 7.  Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research.

Authors:  Nasra Haroun; Laura Dunn; Ansar Haroun; Kristin S Cadenhead
Journal:  Schizophr Bull       Date:  2005-10-05       Impact factor: 9.306

8.  The recognition and optimal management of early psychosis: an evidence-based reform.

Authors:  Patrick D McGorry
Journal:  World Psychiatry       Date:  2002-06       Impact factor: 49.548

Review 9.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

10.  Early psychosis research at Orygen, The National Centre of Excellence in Youth Mental Health.

Authors:  S M Cotton; K M Filia; A Ratheesh; K Pennell; S Goldstone; P D McGorry
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-01       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.